PFBT
KURA icon

Parkside Financial Bank & Trust’s Kura Oncology KURA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$768 Hold
70
– – ﹤0.01% 2494
2026
Q1 		$570 Hold
70
– – ﹤0.01% 2543
2025
Q4 		$728 Hold
70
– – ﹤0.01% 2451
2025
Q3 		$621 Buy
+70
New +$499 ﹤0.01% 2461

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Parkside Financial Bank & Trust's KURA Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Kura Oncology (KURA) position steady in Q2 2026 at 70 shares worth $768. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

Parkside Financial Bank & Trust first reported a position in KURA in Q3 2025 and has held it in 4 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Parkside Financial Bank & Trust held 70 shares of Kura Oncology worth $768 as of Q2 2026.
  • Parkside Financial Bank & Trust left its Kura Oncology share count unchanged in Q2 2026.
  • Kura Oncology made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2494 holding.
  • Parkside Financial Bank & Trust first reported a position in Kura Oncology in Q3 2025 and has held it in 4 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.